| P50 | author | Stephen Holgate | Q1547900 |
| P2093 | author name string | Polosa R | |
| | Rorke S | |
| P2860 | cites work | Mast cell chymase. A potent secretagogue for airway gland serous cells | Q28340689 |
| | Repeatability of bronchial hyperresponsiveness to adenosine-5'-monophosphate (AMP) by a short dosimeter protocol | Q28363320 |
| | Evidence for an A2/Ra adenosine receptor in the guinea-pig trachea | Q28366164 |
| | Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells | Q28508311 |
| | Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions | Q30465722 |
| | Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren's syndrome | Q33563311 |
| | Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease | Q33604898 |
| | Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. | Q33663125 |
| | Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma | Q33775360 |
| | Nomenclature and classification of purinoceptors. | Q34324355 |
| | Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs | Q34564167 |
| | Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness | Q34567774 |
| | Potentiation of adenosine and the adenine nucleotides by dipyridamole | Q34795008 |
| | Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. | Q35532821 |
| | Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjects | Q35533019 |
| | Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages | Q35764915 |
| | Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma | Q35764956 |
| | Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency | Q36120424 |
| | Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children | Q36154040 |
| | Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma | Q36176199 |
| | Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study | Q36209589 |
| | Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness | Q36272812 |
| | Variations in chemical mediators of hypersensitivity in the sputum of chronic bronchitics: correlation with peak expiratory flow | Q39494233 |
| | Effects of some purine derivatives on the guinea-pig trachea and their interaction with drugs that block adenosine uptake | Q40014446 |
| | Role of mast cells and basophils in asthma. | Q40404434 |
| | The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group | Q40737379 |
| | Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. | Q40791336 |
| | Repeated inhalation of bradykinin attenuates adenosine 5'-monophosphate (AMP) induced bronchoconstriction in asthmatic airways | Q41127326 |
| | The human mast cell | Q41355277 |
| | Transforming growth factor-beta 1 mediates mast cell chemotaxis. | Q41461369 |
| | Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma? | Q41665462 |
| | Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects | Q41858531 |
| | Contribution of prostaglandins and thromboxanes to the adenosine and ATP-induced contraction of guinea-pig isolated trachea | Q41890565 |
| | Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation | Q42573624 |
| | Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids | Q43548727 |
| | PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. | Q43636847 |
| | Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine | Q43774789 |
| | The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma | Q44425104 |
| | Adenosine A2B receptors: a novel therapeutic target in asthma? | Q48014863 |
| | The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects | Q49095464 |
| | Increased bronchial responsiveness in primary and secondary Sjögren's syndrome. | Q50534839 |
| | Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. | Q54261836 |
| | The effect of dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects. | Q54326627 |
| | Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5'-monophosphate, and exercise in asthmatic children | Q57116764 |
| | Airway inflammation and hyperresponsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease | Q57892291 |
| | Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5'-monophosphate-induced bronchoconstriction in patients with COPD. | Q64896452 |
| | Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine | Q67535802 |
| | Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma | Q68037940 |
| | The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma | Q68298911 |
| | Enhancing effect of dipyridamole inhalation on adenosine-induced bronchospasm in asthmatic patients | Q68386593 |
| | Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma | Q68917063 |
| | The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5'-monophosphate, and allergen in atopic nonasthmatic subjects | Q68926681 |
| | Adenosine potentiates mediator release from human lung mast cells | Q69048926 |
| | The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma | Q69194476 |
| | The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma | Q69372507 |
| | Effect of indomethacin on adenosine-induced bronchoconstriction | Q69600881 |
| | Adenosine receptors on mouse bone marrow-derived mast cells: functional significance and regulation by aminophylline | Q70219260 |
| | Airway responsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease is determined by smoking | Q70583732 |
| | Bronchial Reactivity in Cystic Fibrosis With Normal Pulmonary Function | Q70930682 |
| | Is there a specific phenotype for asthma? | Q70974530 |
| | Inhaled lysine acetylsalicylate (L-ASA) attenuates the bronchoconstrictor response to adenosine 5'-monophosphate (AMP) in asthmatic subjects | Q71815773 |
| | Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis | Q72399031 |
| | Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma | Q72609120 |
| | Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides | Q72676513 |
| | Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism | Q72752692 |
| | Adenosine receptors and the regulation of adenylate cyclase | Q72907680 |
| | Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma | Q73028987 |
| | Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype | Q73071711 |
| | Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma | Q73227882 |
| | Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis | Q73457477 |
| | Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5' monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze | Q73504594 |
| | Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness | Q73640622 |
| | Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma | Q73784740 |
| | Exercise, methacholine, and adenosine 5'-monophosphate challenges in children with asthma: relation to severity of the disease | Q74267632 |
| | Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness | Q74316549 |
| | Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD | Q74363450 |
| | Adenosine induces histamine release from human bronchoalveolar lavage mast cells | Q74625046 |
| | Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease | Q77660840 |
| | A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients | Q77950250 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 649-654 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease | |
| P478 | volume | 57 | |